TY - JOUR
T1 - Effect of twelve-week concurrent aerobic and resisted exercise training in non-dialysis day on functional capacity and quality of life in chronic kidney disease patients
AU - Kamal Abdelbasset, Walid
AU - Ibrahim, A. A.
AU - Althomali, O. W.
AU - Hussein, H. M.
AU - Alrawaili, S. M.
AU - Alsubaie, S. F.
N1 - Publisher Copyright:
© 2022 Verduci Editore s.r.l. All rights reserved.
PY - 2022
Y1 - 2022
N2 - OBJECTIVE: Several researchers have evaluated the impact of exercise training on patients with chronic kidney disease (CKD). However, few studies have evaluated the impact of concurrent training (aerobic and resisted exercise) on non-dialysis days on the functional capacity and quality of life (QOL) of such patients. Our current study evaluated the effects of concurrent training on functional capacity and QOL of patients with CKD. PATIENTS AND METHODS: Forty-three patients, aged ≥ 25 years, were recruited in this randomized study. They were divided into intervention and control groups (22 per group). The intervention group received concurrent aerobic and resistance exercises (three sessions per week for twelve weeks on alternative days). The control group continued their regular lifestyle practices and medical treatment without any exercise intervention. Before and after twelve weeks of training, the participant’s functional capacity and quality of life (QOL) were measured. RESULTS: Compared to the control group, the intervention group displayed a significant improvement in the distance walked in the 6-min-ute walk test and sit-to-stand test (STS1/s and STS-60) with p<0.001; furthermore, a significant improvement was observed in physical function, body pain, general health, role functioning/physical, vitality, and social functioning (p<0.05) of QOL assessed with the SF-36 questionnaire. CONCLUSIONS: The twelve-week concurrent aerobic and resistance exercise training had a positive impact on functional capacity and QOL in CKD patients. Concurrent exercise training should be recommended as an interventional modality in physical therapy and rehabilitation protocols in CKD patients.
AB - OBJECTIVE: Several researchers have evaluated the impact of exercise training on patients with chronic kidney disease (CKD). However, few studies have evaluated the impact of concurrent training (aerobic and resisted exercise) on non-dialysis days on the functional capacity and quality of life (QOL) of such patients. Our current study evaluated the effects of concurrent training on functional capacity and QOL of patients with CKD. PATIENTS AND METHODS: Forty-three patients, aged ≥ 25 years, were recruited in this randomized study. They were divided into intervention and control groups (22 per group). The intervention group received concurrent aerobic and resistance exercises (three sessions per week for twelve weeks on alternative days). The control group continued their regular lifestyle practices and medical treatment without any exercise intervention. Before and after twelve weeks of training, the participant’s functional capacity and quality of life (QOL) were measured. RESULTS: Compared to the control group, the intervention group displayed a significant improvement in the distance walked in the 6-min-ute walk test and sit-to-stand test (STS1/s and STS-60) with p<0.001; furthermore, a significant improvement was observed in physical function, body pain, general health, role functioning/physical, vitality, and social functioning (p<0.05) of QOL assessed with the SF-36 questionnaire. CONCLUSIONS: The twelve-week concurrent aerobic and resistance exercise training had a positive impact on functional capacity and QOL in CKD patients. Concurrent exercise training should be recommended as an interventional modality in physical therapy and rehabilitation protocols in CKD patients.
KW - Aerobic exercise
KW - Chronic kidney disease
KW - Physical capacity
KW - Psychological status
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=85138233513&partnerID=8YFLogxK
U2 - 10.26355/eurrev_202209_29626
DO - 10.26355/eurrev_202209_29626
M3 - Article
C2 - 36111910
AN - SCOPUS:85138233513
SN - 1128-3602
VL - 26
SP - 6098
EP - 6106
JO - European Review for Medical and Pharmacological Sciences
JF - European Review for Medical and Pharmacological Sciences
IS - 17
ER -